Fiche du document
2022
- doi: 10.18632/oncotarget.28176
- issn: 1949-2553
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.18632/oncotarget.28176
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35070081
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1949-2553
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_795607B9FBDB5
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
Ketohydroxyestrone Theelin Hydroxyestratrieneone Thelykinin Tokokin Ketohydroxyestrin Follicular hormone Folliculin OestroneCiter ce document
M.R. Woodford et al., « Seventh BHD international symposium: recent scientific and clinical advancement. », Serveur académique Lausannois, ID : 10.18632/oncotarget.28176
Métriques
Partage / Export
Résumé
The 7th Birt-Hogg-Dubé (BHD) International Symposium convened virtually in October 2021. The meeting attracted more than 200 participants internationally and highlighted recent findings in a variety of areas, including genetic insight and molecular understanding of BHD syndrome, structure and function of the tumor suppressor Folliculin (FLCN), therapeutic and clinical advances as well as patients' experiences living with this malady.